Esther Rajavelu

Stock Analyst

(n/a)
# 3,404
Out of 4,234 analysts
16
Total ratings
n/a
Success rate
n/a
Average return
Stock Action Price Target Current Upside Ratings Updated
ALNY
Alnylam Pharmaceuticals
Upgrades: Buy n/a $172.87 - 1 Oct 4, 2021
RARE
Ultragenyx Pharmaceutical
Initiates: Sell n/a $41.22 - 1 Aug 19, 2021
BHVN
Biohaven Pharmaceutical Holding Company
Downgrades: Neutral n/a $33.94 - 4 Aug 10, 2021
STOK
Stoke Therapeutics
Initiates: Neutral n/a $4.20 - 1 May 18, 2021
DNLI
Denali Therapeutics
Initiates: Buy n/a $18.77 - 1 May 18, 2021
IONS
Ionis Pharmaceuticals
Upgrades: Neutral n/a $51.46 - 2 May 7, 2021
JAZZ
Jazz Pharmaceuticals
Maintains: Buy n/a $121.45 - 1 Mar 1, 2021
ORTX
Orchard Therapeutics
Maintains: Outperform n/a $16.22 - 1 Apr 1, 2020
EYEN
Eyenovia
Downgrades: Perform n/a $1.37 - 1 Feb 3, 2020
ARWR
Arrowhead Pharmaceuticals
Initiates: Perform n/a $24.93 - 1 Dec 13, 2019
INVA
Innoviva
Initiates: Hold n/a $14.39 - 1 Nov 20, 2017
TXMD
TherapeuticsMD
Initiates: Buy n/a $2.54 - 1 Jul 21, 2017